Pacira BioSciences Inc (NAS:PCRX)
$ 16.81 -0.7 (-4%) Market Cap: 776.17 Mil Enterprise Value: 998.18 Mil PE Ratio: 0 PB Ratio: 1.03 GF Score: 72/100

Pacira Biosciences Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 04:15PM GMT
Release Date Price: $33.17 (-4.49%)
Hardik Parikh

Hi, everybody. Welcome to day 3 of the JPMorgan Healthcare Conference. My name is Hardik Parikh. I work in the equity research team covering large cap biopharma for U.S. I want to welcome Frank Lee, the freshly minted CEO of Pacira up to the floor.

Frank D. Lee
Pacira BioSciences, Inc. - CEO & Director

Thanks, Hardik and good morning, everybody. After what 5 days on the job, I can tell you, I've got it almost figured out, give me another day.

I thought I'd start with a little bit of a bio about myself and maybe answer the question that many of you have, which is why Pacira. Why Pacira, Frank? And so just a little bit of bio, 30-plus years in the industry, most recently as CEO of Forma Therapeutics. We took a company there. I took over the reins from a CEO founder, who've been there a while. We pivoted the company, built a great team and took the company public. And after a while, a company by the name of Novo Nordisk took interest and acquired the company about a year ago. So that was most recently. And prior to that, I spent a lot of time

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot